LEXENT BIO

Novel liquid biopsy technology to change the way we manage cancer

 

BETTER TREATMENT DECISIONS, FASTER

Our liquid biopsy technology will help oncologists and their patients understand if they are responding to treatment, sooner and more accurately than currently possible.

LIQUID BIOPSY

Blood contains abundant information about a patient's tumor and immune response, from cells, nucleic acids, and small vesicles from the tumor and its environment. Advances in biology and technology enable a simple blood draw - a liquid biopsy - to provide clinically actionable information about cancer diagnosis and treatment.

TRACKING RESPONSE TO TREATMENT

Many cancer therapies are available, but they may not work in every patient. Lexent Bio is developing technology to let clinicians monitor response to therapy, faster than imaging, to quickly identify the most effective treatment.

MOVING SCIENCE FORWARD

Lexent Bio is a dedicated collection of clinicians, scientists, and engineers proudly working to translate scientific advancements into cost-effective and scalable clinical practice —for all of us and those we love.

Client Services: (888) 988-3639 client.services@foundationmedicine.com

Biopharma Solutions: biopharma@foundationmedicine.com

©2020 FOUNDATION MEDICINE, INC.

150 Second Street, Cambridge, MA 02141  •  (617) 418-2200